Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/29A stock hub

FRA/29A has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/29Ais not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
711.8M
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/29AFRA/29A
Loading chart…
In the news

Latest news · FRA/29A

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E5.6
P25 n/aP50 n/aP75 n/a
Trailing P/E10.4
P25 n/aP50 n/aP75 n/a
ROE10.4
P25 n/aP50 n/aP75 n/a
ROIC9.3
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/29A market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
213
Groups with data
11
Currency
USD
Showing 213 of 213 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
DE
Employees
1,976
Employees Change
267%
Employees Change Percent
15.16
Enterprise value
EUR 1B
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
EUR 711.8M
Price
EUR 18.03
Price currency
EUR
Rev Per Employee
316,252.87x
Sic
2834
Symbol
fra/29A
Website
https://www.amphastar.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
9.65%
EV Earnings
15.23x
EV/EBIT
8.81x
EV/EBITDA
5.91x
EV/FCF
8.93x
EV/Sales
1.71x
FCF yield
16.47%
Forward P/E
5.55x
P/B ratio
1.06x
P/E ratio
10.36x
P/S ratio
1.14x
PE Ratio10 Y
277.83x
PE Ratio3 Y
14.13x
PE Ratio5 Y
19.83x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
19.41%
EBITDA Margin
27.38%
FCF margin
18.76%
Gross margin
47.34%
Gross Profit
EUR 295.9M
Gross Profit Growth
-7.55%
Gross Profit Growth Q
-17.51%
Gross Profit Growth3 Y
8.16%
Gross Profit Growth5 Y
17.63%
Net Income
EUR 68.7M
Net Income Growth
-44.06%
Net Income Growth Q
-74.61%
Net Income Growth3 Y
-5.26%
Net Income Growth5 Y
99.69%
Pretax Margin
14.27%
Profit Margin
11%
Profit Per Employee
EUR 34,775
ROA
5.34
Roa5y
8.4
ROCE
9.43
ROE
10.39
Roe5y
18.53
ROIC
9.25
Roic5y
16.37

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

21
MetricValue
Cagr10y
5.81%
Cagr1y
-12.53%
Cagr3y
-18.57%
Cagr5y
2.81%
EPS Growth
-39.73
EPS Growth Q
-72.55
EPS Growth3 Y
-1.98
EPS Growth5 Y
100.2
FCF Growth
-10.01%
FCF Growth Q
57.23%
FCF Growth3 Y
38.01%
FCF Growth5 Y
24.53%
OCF Growth
-12.58%
OCF Growth Q
36.39%
OCF Growth10 Y
21.92%
OCF Growth3 Y
28.93%
OCF Growth5 Y
16.52%
Revenue Growth
-1.39x
Revenue Growth Q
0.38x
Revenue Growth3 Y
11.58x
Revenue Growth5 Y
14.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
EUR 0.44
Assets
EUR 1.4B
Cash
EUR 253.2M
Current Assets
EUR 537.3M
Current Liabilities
EUR 139.5M
Debt
EUR 595.3M
Debt EBITDA
EUR 3.29
Debt Equity
EUR 0.89
Debt FCF
EUR 5.08
Equity
EUR 670.8M
Interest Coverage
5.56
Liabilities
EUR 758.7M
Long Term Assets
EUR 892.1M
Long Term Liabilities
EUR 619.2M
Net Cash
EUR -342.1M
Net Cash By Market Cap
EUR -48.06
Net Debt EBITDA
EUR 2
Net Debt Equity
EUR 0.51
Net Debt FCF
EUR 2.92
Tangible Book Value
EUR 185.4M
Tangible Book Value Per Share
EUR 4.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
3.85
Inventory Turnover
2.13
Net Working Capital
EUR 163.6M
Quick ratio
2.73
Working Capital
EUR 406.9M
Working Capital Turnover
EUR 1.46

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
7.65%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
10Y total return
75.9%
1Y total return
-12.52%
200-day SMA
21.06
3Y total return
-46.02%
50-day SMA
17.41
50-day SMA vs 200-day SMA
50under200
5Y total return
14.84%
All Time High
59
All Time High Change
-69.44%
All Time High Date
2023-08-09
All Time Low
10.13
All Time Low Change
77.92%
All Time Low Date
2016-05-09
ATR
0.54
Ch YTD
-18.93
High
18.03
High52
25.96
High52 Date
2025-09-02
High52ch
-30.55%
Low
18.02
Low52
15.26
Low52 Date
2026-03-13
Low52ch
18.15%
Ma50ch
3.55%
Price vs 200-day SMA
-14.38%
RSI
49.33
RSI Monthly
37.99
RSI Weekly
43.11
Sharpe ratio
-0.17x
Sortino ratio
-0.13
Total Return
7.65%
Tr YTD
-18.93
Tr1m
3.95%
Tr1w
-0.77%
Tr3m
-24.08%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 121.3M
Operating Income Growth
-28.18
Operating Income Growth Q
-63.45
Operating Income Growth3 Y
4.65
Operating Income Growth5 Y
54.12
Operating margin
19.41

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
32,838,616%
Net Borrowing
3,697,114.3
Shares Insiders
10.02%
Shares Institutions
76.44%
Shares Qo Q
-1.5%
Shares Yo Y
-7.65%
Short Ratio
7.18

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

60
MetricValue
Adjusted FCF
EUR 92.8M
Average Volume
10x
Bv Per Share
15.03
CAPEX
EUR -29.2M
Ch10y
75.9
Ch1m
3.95
Ch1w
-0.77
Ch1y
-12.52
Ch3m
-24.08
Ch3y
-46.02
Ch5y
14.84
Ch6m
-12.86
Change
-9.26%
Change From Open
0.06
Close
19.87
Days Gap
-9.31
Depreciation Amortization
48,701,849.5
Dollar Volume
3,606
Earnings Date
2026-05-07
EBIT
EUR 121.3M
EBITDA
EUR 171.1M
EPS
EUR 1.45
F Score
5
FCF
EUR 117.2M
FCF EV Yield
11.2x
Financing CF
-72,097,782
Fiscal Year End
December
Founded
1,996
Goodwill
2,823,713.5
Graham Number
25.79651
Graham Upside
43.08
Income Tax
EUR 20.5M
Investing CF
-84,601,646
Is Primary Listing
0
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Lynch Fair Value
EUR 43.52
Lynch Upside
141.4
Ma150
20.53
Ma150ch
-12.19%
Ma20
18.13
Ma20ch
-0.54%
Net CF
-10,271,434
Next Earnings Date
2026-08-07
Open
18.02
P FCF Ratio
6.07
P OCF Ratio
4.86
Position In Range
100
Ppne
321,302,977.3
Price Date
2026-05-08
Price EBITDA
EUR 4.16
Ptbv Ratio
3.84
Revenue
624,915,669x
SBC By Revenue
3.91x
Share Based Comp
24,421,433
Tax By Revenue
3.27x
Tax Rate
22.94%
Tr6m
-12.86%
Volume
200
Z Score
2.44
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/29A pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/29A stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-12.5%
S&P 500 1Y: n/a
3Y total return
-46.0%
S&P 500 3Y: n/a
5Y total return
+14.8%
S&P 500 5Y: n/a
10Y total return
+75.9%
S&P 500 10Y: n/a
Ownership

Who owns FRA/29A?

Insider, institutional, and short-interest positioning.

Institutional ownership
+76.4%
Share of float held by funds and institutions
Insider ownership
+10.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
7.2 days to cover
Y/Y dilution
-7.6%
Negative means the company is buying back shares.
Technical

FRA/29A momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
49.3
Neutral momentum band
Price vs 200-day MA
-14.4%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
-0.17
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/29A

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/29A stock rating?

fra/29A is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/29A analysis?

The full report lives at /stocks/fra/29A/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/29A?

The latest report frames fra/29A around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/29A page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.